CorrespondenceComparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant–negative patients with bee venom allergy
References (7)
- et al.
Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy
J Allergy Clin Immunol
(2011) - et al.
Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of α-1,3-core fucosylation
Mol Immunol
(2010) - et al.
Added value of IgE detection to rApi m 1 and rVes v 5 in patients with Hymenoptera venom allergy
J Allergy Clin Immunol
(2011)
Cited by (38)
Basophil Activation Test in Double-Sensitized Patients With Hymenoptera Venom Allergy: Additional Benefit of Component-Resolved Diagnostics
2023, Journal of Allergy and Clinical Immunology: In PracticeGlycosylation enhances allergenic activity of major bee venom allergen Api m 1 by adding IgE epitopes
2021, Journal of Allergy and Clinical ImmunologyInsect venom phospholipases A1 and A2: Roles in the envenoming process and allergy
2019, Insect Biochemistry and Molecular BiologyCitation Excerpt :Consequently, several efforts were conducted to produce native-like, CCD-lacking form of this allergen (Eberlein et al., 2012; Hemmer et al., 2001; Seismann et al., 2010a). Currently, CCDs-free variants of Api m 1 produced in Spodoptera frugiperda (Sf9) cells are widely used in routine molecular diagnosis for specific identification of HBV allergy (Blank et al., 2011; Jakob et al., 2017a, 2012). PLA2s have been also identified as major venom allergens in other members of Apis genus such as A. cerana (Api c 1) as well as bumble bees (Table 1) (Hoffman and Jacobson, 1996; Shen et al., 2010; Xin et al., 2009).
Comparing sensitivity of Hymenoptera allergen components on different diagnostic assay systems: Comparing apples and oranges?
2017, Journal of Allergy and Clinical ImmunologyInsect sting allergy
2016, Pediatric Allergy: Principles and Practice: Third EditionIgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology
2015, Molecular ImmunologyCitation Excerpt :However, sensitization to rApi m 1 in HBV allergy is less frequent than previously anticipated. Depending on the patient population, between 20% and 42% of the HBV allergic patients lacks IgE reactivity to rApi m 1 (Hofmann et al., 2011b; Korosec et al., 2011, 2012; Sturm et al., 2011; Jakob et al., 2012). Therefore, additional HBV allergens appear to be relevant in HBV allergy.
Supported in part by a research grant of Thermo Fisher Scientific, Germany (to T.J.).
Disclosure of potential conflicts of interest: J. Lidholm and U. Magnusson are employed by Thermo Fisher Scientific. T. Jakob has received research support from the German Research Council, Landesstiftung Baden-Wurttemberg, COLIPA, Birken GmbH, Allergopharma, and Phadia/Thermo Fischer and is a board member of the European Immunodermatology Society and the German Society of Allergy & Clinical Immunology. The rest of the authors declare that they have no relevant conflicts of interest.